Breast cancer

June 7, 2020

Now Enrolling: The CompassHER2 pCR trial is determining if certain patients with early-stage HER2 positive breast cancer may benefit from reduced chemotherapy

The purpose of this study is to find out if some patients with early-stage HER2 positive breast cancer can safely be treated with less chemotherapy than is generally used.
October 14, 2019

Lynne Alston: Why I’m grateful for researchers

Lynne Alston is a thought leader, entrepreneur, international best-selling author of A Hug Saved My Life™, cancer survivor and advocate, community ambassador, life and wellness coach, and the founder/chief executive officer of the HUGS Around America™ Foundation.
October 14, 2019

Dr. Debby Olusa: My tribute to researchers

Dr. Debby Olusa is a global thought leader, entrepreneur, international speaker, best-selling co-author of Fearless Visionaries – Volume 2, breast cancer child caregiver advocate, model, and the founder/chief executive officer of Olusa Associates, LLC.